Table 2.
Case Reports of Alectinib-related Anemia.
| Reference number | Age/ Gender |
Disesases | DAT | Erythrocyte morphological change | Decrease of Hpt |
|---|---|---|---|---|---|
| (3) | 85/M | NSCLC | Negative | (+) | (+) |
| (4) | 62/M | NSCLC, α-thalassaemia | Negative | (+) | (+) |
| (5) | 66/M | NSCLC, β-thalassaemia | Negative | (+) | (+) |
| 77/F | NSCLC | Negative | (+) | (-) | |
| (6) | 79/F | NSCLC | No mention | (+) | No mention |
| 66/M | NSCLC | No mention | (+) | No mention | |
| 14/F | NSCLC | Negative | (+) | (-) | |
| 30/F | Neuroblastoma | No mention | (+) | (-) | |
| 66/M | NSCLC, β-thalassaemia | Negative | (+) | (+) | |
| 77/F | NSCLC | Negative | (+) | (+) |
DAT: direct antiglublin test, Hpt: haptoglobin, NSCLC: non-small cell lung carcinoma